EP2217292A1 - Surgical prosthesis for plastic reconstruction - Google Patents
Surgical prosthesis for plastic reconstructionInfo
- Publication number
- EP2217292A1 EP2217292A1 EP08845613A EP08845613A EP2217292A1 EP 2217292 A1 EP2217292 A1 EP 2217292A1 EP 08845613 A EP08845613 A EP 08845613A EP 08845613 A EP08845613 A EP 08845613A EP 2217292 A1 EP2217292 A1 EP 2217292A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- prosthesis
- hydrophilic
- elastomer
- silicone
- implant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229920003023 plastic Polymers 0.000 title claims abstract description 6
- 241000894006 Bacteria Species 0.000 claims abstract description 25
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 17
- 229920001296 polysiloxane Polymers 0.000 claims description 37
- 229920001971 elastomer Polymers 0.000 claims description 14
- 239000000806 elastomer Substances 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 13
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 239000011859 microparticle Substances 0.000 claims description 8
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 6
- 229910052709 silver Inorganic materials 0.000 claims description 6
- 239000004332 silver Substances 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 5
- 230000000844 anti-bacterial effect Effects 0.000 claims description 4
- 230000003385 bacteriostatic effect Effects 0.000 claims description 4
- 230000004048 modification Effects 0.000 claims description 4
- 238000012986 modification Methods 0.000 claims description 4
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 2
- 239000000956 alloy Substances 0.000 claims 1
- 229910045601 alloy Inorganic materials 0.000 claims 1
- 238000011109 contamination Methods 0.000 claims 1
- 230000004060 metabolic process Effects 0.000 claims 1
- 239000000377 silicon dioxide Substances 0.000 claims 1
- 229940100890 silver compound Drugs 0.000 claims 1
- 150000003379 silver compounds Chemical class 0.000 claims 1
- 239000007943 implant Substances 0.000 description 34
- 206010062575 Muscle contracture Diseases 0.000 description 8
- 208000006111 contracture Diseases 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 239000002775 capsule Substances 0.000 description 6
- 229920002379 silicone rubber Polymers 0.000 description 5
- 210000000481 breast Anatomy 0.000 description 4
- 238000002513 implantation Methods 0.000 description 4
- 241000191940 Staphylococcus Species 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 210000004872 soft tissue Anatomy 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000002095 exotoxin Substances 0.000 description 2
- 231100000776 exotoxin Toxicity 0.000 description 2
- 150000002433 hydrophilic molecules Chemical class 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- 208000031504 Asymptomatic Infections Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010070245 Foreign body Diseases 0.000 description 1
- 208000005422 Foreign-Body reaction Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 229940064804 betadine Drugs 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 230000000513 bioprotective effect Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008029 eradication Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 125000003010 ionic group Chemical group 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 244000005714 skin microbiome Species 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A61L2300/104—Silver, e.g. silver sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
Definitions
- the present invention relates to a prosthesis intended to be implanted in a human body for plastic reconstitution, and more particularly to a soft tissue body prosthesis, and more specifically to a prosthesis or a breast implant.
- a well-known problem with breast implants is capsular contracture.
- Capsular contracture is the condition that occurs in approximately 5% of women, and in which the capsule surrounding the implant contracts in an attempt to isolate the implant from the rest of the body because a bacterial infection has occurred. developed. If this capsular contracture is not treated, it can lead to extrusion or permanent damage to the implant.
- Silicone elastomers have long been used in the manufacture of devices that can be implanted in the human body because they are chemically stable with the body as well as non-toxic.
- Staphylococcus epidermitis An example of such skin bacteria often isolated in association with capsular contracture is Staphylococcus epidermitis.
- This bacterium is an opportunistic bacterium that is not normally associated with an infection. It can, however, produce a bio film surrounding the bacteria that can be protective of the environment. The bacteria will preferably attach to a solid support and can then multiply. The bio film layer is the virulence factor that allows Staphylococcus epidermitis to survive where other bacteria are destroyed by the normal immune system. The bacteria can live for long periods of time with low metabolic rate.
- the bacterium Staphylococcus epidermitis can therefore attach to the silicone implant, especially during implantation, when a relatively large implant has passed through a small relative incision in the skin.
- the implant becomes colonized by the bacterium because of the high hydrophobicity of the external surface of the implant, (generally silicone for soft tissue prostheses) and the surface of the bacterium are both highly hydrophobic, and attract solids in a non-specific way. This allows the information of a bio film to slow growth on the external surface of the implant.
- these bacteria grow slowly, they can adhere to the external surface of the implant, remain dormant during periods of time equilibrium with the host, sometimes for several years, and then, for example, because of stress on the body, the bacteria stops living in balance with the body's immune system. At this time, under such imbalanced trigger conditions, the bacterium can rapidly replicate or at least exude exotoxins into its environment and cause inflammation on and around the capsule. Typical triggering conditions include loss or decrease in immune status due to diseases, drug treatments, etc., which will allow the bacteria to multiply.
- EP-0 057 033 and FR-2 822 383 describe methods for modifying the surfaces of breast implants. These methods are complex and therefore expensive to implement.
- the present invention aims to provide a prosthesis intended to be implanted in a human body for plastic reconstitution, which does not reproduce the aforementioned drawbacks.
- the present invention aims to provide a prosthesis, including a silicone breast prosthesis, for which the risks of capsular contracture are reduced.
- the present invention also aims to provide such a prosthesis which is simple and inexpensive to manufacture and to achieve, and which does not require modifications of the implantation process by the surgeon.
- the present invention therefore relates to a surgical prosthesis intended to be implanted in a human body, as described in claim 1.
- Fig. 1 is a cross-sectional view of a portion of a prosthesis, where the outer surface of the prosthesis is a silicone elastomer which is chemically modified to render it hydrophilic;
- Fig. 2 is a cross-sectional view of a portion of a prosthesis having a plurality of hydrophilic microparticles partially embedded in the outer surface of the prosthesis;
- Figure 3 is a cross-sectional view of a portion of a prosthesis having a hydrophilic layer coated on the outer surface of the prosthesis.
- the present invention consists in responding to the problem of post-implantation capsular contracture by attacking the hydrophobic / hydrophobic interaction between the surface of the prosthesis, which in the prior art is generally a hydrophobic surface, and potentially colonizing bacteria, also hydrophobic. If one disrupts the ability of the outer surface to become a substrate or a support for bacterial growth, then the bacterium will not be able to attach to this surface or produce a bio-protective film, with the adverse consequences induced described above. If the bacterium remains in a hydrophilic tissue and / or a hydrophilic fluid, then it will not be able to attach to the surface of the prosthesis, and the normal immune response of the host will "clean" the bacterium in a known manner.
- the invention therefore provides for making the prosthesis hydrophilic, made of elastomer, in particular silicone, to prevent any bacterial growth.
- the preferred embodiment of the invention which provides for chemically modifying the side and / or end groups of the silicone chain to make them more hydrophilic, will be described hereinafter in more detail.
- basic silicone building blocks (or chains) which are normally hydrophobic, are chemically modified to render the molecule hydrophilic. This can be achieved by substituting the methyl groups along the silicone backbone by any group hydrophilic. Examples of these hydrophilic groups could be (but not limited to) alcohols, ionic groups, organic molecules, etc., used alone or in combination with each other. The substitution could be carried out at the end of the molecule, over the entire length of the molecule, or a combination of these two variants. The concentration of the substitution can be modified to alter the importance of hydrophilicity.
- FIG. 1 is a cross-sectional view of a portion of a prosthesis 10 in which at least the outer surface 12 of the prosthesis is a silicone elastomer that is chemically modified to render the external surface hydrophilic.
- the silicone is modified from the outset to make it hydrophilic. After crosslinking, it is thus possible to form an implant that is hydrophilic from the start.
- modifying the surface of an already existing implant which is hydrophobic, as described in documents EP-0 057 033 and FR-2 822 383, requires the use of sophisticated and expensive means.
- the present invention makes it possible to obtain the desired hydrophilic properties in a simpler and less expensive manner.
- the entire prosthesis can be made from the outset from hydrophilic silicone (or other suitable elastomer).
- the invention may also provide for making a hydrophobic silicone prosthesis blank, and then dipping this blank one or more times in a hydrophilic modified silicone, to form one or more hydrophilic outer layers. After baking or crosslinking, the resulting prosthesis will have a hydrophobic internal support structure, and a hydrophilic external surface.
- there is no treatment of the external surface of an implant previously made of hydrophobic silicone but on the contrary, the external surface of the prosthesis is directly made of hydrophilic material during the manufacturing process of the prosthesis.
- Various variants that can be used in addition will be described below.
- These variants may include treatments of the surface of the implant, to further improve the hydrophilic properties of said surface. They may also include the use of a bactericidal and / or bacteriostatic material, in particular silver, especially in ionic form, which will have a non-toxic antimicrobial effect and which can therefore be used to kill or eliminate the bacterium if the one It must still develop on the surface of the prosthesis.
- This antimicrobial material may be embedded in or on the surface of the prosthesis and may, of course, be used in conjunction with hydrophilic surface properties of the prosthesis as mentioned above.
- silicone is the most widely used elastomer for implantable soft tissue prostheses. Consequently, the modification of the external surface of a silicone prosthesis will be described by way of non-limiting example.
- the external surface of a silicone implant according to the invention can be made even more hydrophilic by covalently attaching it to a hydrophilic end group, especially at the end of the manufacturing process, by putting the external surface in contact with a reagent, such as, for example, cyanogen bromide. These types of agents activate the molecule to covalently link it to other molecules, thus fixing molecules preferably over an area in which they were not previously existing.
- hydrophilic molecules can be covalently attached to the surface of the implant, making it even more hydrophilic.
- a hydrophobic end group may be covalently attached to the silicone surface, and subsequently separated, either chemically biologically, to render the surface hydrophilic.
- Still another method for rendering the outer surface of a silicone implant hydrophilic is to coat the silicone outer surface of the implant with silicone comprising monomers having both a hydrophobic end group and an end group opposite hydrophilic, to form the outermost layer. This "bipolar" silicone could be hydrophobically bonded to the silicone outer surface of the implant, leaving the opposing hydrophilic group exposed to the environment.
- the surface of the silicone implant may be coated with a hydrophobic-hydrophilic micelle.
- Fig. 2 is a cross-sectional view of a portion of a prosthesis 20 having a plurality of biocompatible hydrophilic particles 21 partially embedded in the outer surface 22.
- a prosthesis can be made by several manufacturing methods.
- a preferred method comprises the steps of forming a silicone shell by repeatedly dipping a prosthesis mandrel into a silicone dispersion, whereby the coating formed between the dives is fired. After the final layer of the silicone elastomer is formed on the outer surface and the shell is of desired thickness, a coating of solid microparticles of a biocompatible hydrophilic material is applied to the surface before the outermost layer is completely cooked.
- the biocompatible hydrophilic material may be hydrophilic throughout the entire microparticle or only on the surface of said microparticle.
- the silicone is completely cooked (for example by heating), so that an embedded portion of the microparticles is embedded in the fired outer layer of silicone and an exposed portion of the microparticles. extends outward from the silicone surface.
- the prosthesis thus formed can be implanted in the body of a person.
- hydrophilic biopolymers such as collagen and hyaluronic acid
- synthetic hydrophilic polymers such as polyvinylpyrrolidone
- FIG. 3 is a cross-sectional view of a portion of a prosthesis 30 having a hydrophilic layer or film 31 coated on the outer surface 32 of the implant.
- Such biocompatible hydrophilic film 31 may be attached to either a smooth surface or a textured surface of a silicone implant.
- Any solution, cream, compound, material, gel, that is reabsorbable in the body and that can interfere with the ability of a hydrophobic-hydrophobic interaction, can be used at the time of surgery to modify, break or interrupt the hydrophobic interaction -hydrophobe.
- This may for example include (but not limited to) lubricating materials for implant insertion, anti-adhesion materials, betadine, etc. These materials can be added directly to the implant pocket, on the surface of the implant itself, or a combination of both.
- Silver is well known to be a metal with therapeutic and low-toxicity capabilities. man. It can be bactericidal and / or bacteriostatic. Money or compounds containing money or silver nanoparticles, especially in ionic form, could be incorporated in the silicone or embedded in the surface of the prosthesis. Silver in any form can be used in conjunction with a previously mentioned hydrophilic external surface, or alone.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Abstract
Surgical prosthesis (10; 20; 30) designed to be implanted in a body for the purpose of plastic reconstruction, said prosthesis (10; 20; 30) being in contact with tissues of the body, said prosthesis (10; 20; 30) having an outer surface (12; 22; 32) which is hydrophilic in order to at least partially prevent the attachment and/or development of bacteria, especially of the hydrophobic type, on said outer surface (12; 22; 32).
Description
Prothèse chirurgicale pour la reconstitution plastique Surgical prosthesis for plastic reconstitution
La présente invention concerne une prothèse destinée à être implantée dans un corps humain pour la reconstitution plastique, et plus particulièrement une prothèse de corps en tissu mou, et plus spécifiquement une prothèse ou un implant mammaire. Un problème bien connu qui se pose avec les implants mammaires est la contracture capsulaire. La formation d'une capsule autour d'un objet étranger placé dans le corps est une conséquence normale de l'implantation. La contracture capsulaire est la condition qui se produit chez environ 5% des femmes, et dans laquelle la capsule qui entoure l'implant se contracte dans une tentative d'isoler l'implant du reste du corps parce qu'une infection bactérienne s'est développée. Si cette contracture capsulaire n'est pas traitée, elle peut mener à une extrusion ou un endommagement définitif de l'implant. Les élastomères de silicone ont depuis longtemps été utilisés pour la fabrication de dispositifs pouvant être implantés dans le corps humain parce qu'ils sont chimiquement stables avec le corps ainsi que non toxiques.The present invention relates to a prosthesis intended to be implanted in a human body for plastic reconstitution, and more particularly to a soft tissue body prosthesis, and more specifically to a prosthesis or a breast implant. A well-known problem with breast implants is capsular contracture. The formation of a capsule around a foreign object placed in the body is a normal consequence of implantation. Capsular contracture is the condition that occurs in approximately 5% of women, and in which the capsule surrounding the implant contracts in an attempt to isolate the implant from the rest of the body because a bacterial infection has occurred. developed. If this capsular contracture is not treated, it can lead to extrusion or permanent damage to the implant. Silicone elastomers have long been used in the manufacture of devices that can be implanted in the human body because they are chemically stable with the body as well as non-toxic.
Toutefois malgré le caractère relativement inerte des élastomères de silicone, ceux-ci peuvent provoquer une réaction de corps étranger chez certains patients. Lorsqu'une substance étrangère pénètre dans un tissu humain, la réaction naturelle et immédiate des tissus entourant la substance étrangère est de la rendre inoffensive pour le reste du corps. Un corps étranger inerte et volumineux est ainsi encapsulé dans une couche de tissu fibreux pour l'isoler des tissus environnants. Il s'agit là d'un mécanisme de défense qui se produit dans un processus similaire à la formation d'un tissu cicatriciel suite à une blessure ou à une incision chirurgicale. Une capsule de tissu fibreux se formera autour et entourera complètement un dispositif implanté, tel qu'une prothèse permanente, et ceci d'une manière intime en se conformant aux formes et aux courbes respectives du dispositif implanté.However, despite the relatively inert nature of silicone elastomers, these can cause a foreign body reaction in some patients. When a foreign substance enters a human tissue, the natural and immediate reaction of the tissues surrounding the foreign substance is to render it harmless to the rest of the body. An inert and bulky foreign body is thus encapsulated in a layer of fibrous tissue to isolate it from surrounding tissues. This is a defense mechanism that occurs in a process similar to the formation of scar tissue following an injury or surgical incision. A fibrous tissue capsule will form around and completely surround an implanted device, such as a permanent prosthesis, and this in an intimate manner by conforming to the respective shapes and curves of the implanted device.
De nombreuses hypothèses ont été proposées pour expliquer le mécanisme de la contraction capsulaire. Toutefois le mécanisme le plus probable implique une infection sub-clinique où des bactéries normalement
présentes dans une certaine mesure sur la peau, sont introduites sur la surface de l'implant en silicone pendant la mise en place de l'implant. Ces bactéries croissent lentement et produisent un bio film sur la surface en contact avec les tissus environnants de la prothèse. Les organismes comprenant le bio film peuvent relâcher des exotoxines qui peuvent avoir un effet à large spectre à la fois localement et systémiquement. Un de ces effets est l'irritation de la capsule. Il est supposé que lorsque la capsule est irritée, la réponse immunitaire du corps tente d'isoler l'implant afin de résoudre le problème ce qui peut résulter en une contracture capsulaire. Les bactéries responsables de la contracture capsulaire sont généralement des bactéries à croissance lente et très hydrophobes afin de résister au dessèchement de la peau. Un exemple de telles bactéries de peau souvent isolées en association avec la contracture capsulaire est le Staphylococcus epidermitis. Cette bactérie est une bactérie opportuniste qui n'est normalement pas associée avec une infection. Elle peut toutefois produire un bio film entourant la bactérie qui peut être protecteur par rapport à l'environnement. La bactérie se fixera de préférence à un support solide et pourra alors se multiplier. La couche de bio film est le facteur de virulence qui permet au Staphylococcus epidermitis de survivre là où d'autres bactéries sont détruites par le système immunitaire normal. La bactérie peut ainsi vivre pendant de longues périodes de temps avec une faible vitesse métabolique.Many hypotheses have been proposed to explain the mechanism of capsular contraction. However the most likely mechanism involves a sub-clinical infection where bacteria normally present to a certain extent on the skin, are introduced on the surface of the silicone implant during the placement of the implant. These bacteria grow slowly and produce a bio film on the surface in contact with the surrounding tissues of the prosthesis. Organisms comprising the bio film can release exotoxins that can have a broad-spectrum effect both locally and systemically. One of these effects is the irritation of the capsule. It is assumed that when the capsule is irritated, the body's immune response attempts to isolate the implant to resolve the problem which may result in capsular contracture. The bacteria responsible for capsular contracture are usually slow-growing and highly hydrophobic bacteria to resist drying out of the skin. An example of such skin bacteria often isolated in association with capsular contracture is Staphylococcus epidermitis. This bacterium is an opportunistic bacterium that is not normally associated with an infection. It can, however, produce a bio film surrounding the bacteria that can be protective of the environment. The bacteria will preferably attach to a solid support and can then multiply. The bio film layer is the virulence factor that allows Staphylococcus epidermitis to survive where other bacteria are destroyed by the normal immune system. The bacteria can live for long periods of time with low metabolic rate.
Il est pratiquement impossible de stériliser complètement la peau. On peut réduire le nombre d'organismes mais une éradication complète est impossible. Par conséquent, il y aura toujours des bactéries sur la peau susceptibles de contaminer le champ chirurgical. La bactérie Staphylococcus epidermitis peut donc se fixer à l'implant en silicone, notamment pendant l'implantation, lorsqu'un implant relativement grand est passé à travers une incision relative petite dans la peau. L'implant devient colonisé par la bactérie en raison de la haute hydrophibicité de la surface externe de l'implant, (généralement du silicone pour les prothèses en tissu mou) et la surface de la bactérie sont toutes deux hautement hydrophobes, et s'attirent les solides de manière non spécifique. Ceci permet l'information d'un bio film à
croissance lente sur la surface externe de l'implant. Puisque ces bactéries croissent lentement, elles peuvent adhérer à la surface externe de l'implant, y rester dormantes pendant les périodes d'étendue de temps en équilibre avec l'hôte, parfois pendant plusieurs années, et ensuite, par exemple, en raison de contrainte sur le corps, la bactérie cesse de vivre en équilibre avec le système immunitaire du corps. A ce moment là, dans des conditions de déclenchement déséquilibrées de ce type, la bactérie peut rapidement se reproduire ou au moins exsuder les exotoxines dans son environnement et causer une inflammation sur et autour de la capsule. Parmi les conditions de déclenchement classiques, on peut citer une perte ou une diminution du statut immunitaire en raison de maladies, de traitements médicamenteux, etc., qui permettront à la bactérie de se multiplier.It is almost impossible to completely sterilize the skin. The number of organisms can be reduced, but complete eradication is impossible. As a result, there will always be bacteria on the skin that can contaminate the surgical field. The bacterium Staphylococcus epidermitis can therefore attach to the silicone implant, especially during implantation, when a relatively large implant has passed through a small relative incision in the skin. The implant becomes colonized by the bacterium because of the high hydrophobicity of the external surface of the implant, (generally silicone for soft tissue prostheses) and the surface of the bacterium are both highly hydrophobic, and attract solids in a non-specific way. This allows the information of a bio film to slow growth on the external surface of the implant. Since these bacteria grow slowly, they can adhere to the external surface of the implant, remain dormant during periods of time equilibrium with the host, sometimes for several years, and then, for example, because of stress on the body, the bacteria stops living in balance with the body's immune system. At this time, under such imbalanced trigger conditions, the bacterium can rapidly replicate or at least exude exotoxins into its environment and cause inflammation on and around the capsule. Typical triggering conditions include loss or decrease in immune status due to diseases, drug treatments, etc., which will allow the bacteria to multiply.
Les documents EP-O 057 033 et FR-2 822 383 décrivent des méthodes pour modifier les surfaces d'implants mammaires. Ces méthodes sont complexes et donc coûteuses à mettre en œuvre.EP-0 057 033 and FR-2 822 383 describe methods for modifying the surfaces of breast implants. These methods are complex and therefore expensive to implement.
La présente invention a pour but de fournir une prothèse destinée à être implantée dans un corps humain pour la reconstitution plastique, qui ne reproduit pas les inconvénients susmentionnés.The present invention aims to provide a prosthesis intended to be implanted in a human body for plastic reconstitution, which does not reproduce the aforementioned drawbacks.
Plus particulièrement, la présente invention a pour but de fournir une prothèse, notamment une prothèse mammaire en silicone, pour laquelle les risques de contracture capsulaire sont diminués.More particularly, the present invention aims to provide a prosthesis, including a silicone breast prosthesis, for which the risks of capsular contracture are reduced.
La présente invention a également pour but de fournir une telle prothèse qui soit simple et peu coûteuse à fabriquer et à réaliser, et qui ne nécessite pas de modifications du processus d'implantation par le chirurgien. La présente invention a donc pour objet une prothèse chirurgicale destinée à être implantée dans un corps humain, telle que décrite dans la revendication 1.The present invention also aims to provide such a prosthesis which is simple and inexpensive to manufacture and to achieve, and which does not require modifications of the implantation process by the surgeon. The present invention therefore relates to a surgical prosthesis intended to be implanted in a human body, as described in claim 1.
Des modes de réalisation avantageux sont décrits dans les revendications dépendantes. Ces caractéristiques et avantages et d'autres de la présente invention apparaîtront plus clairement au cours de la description détaillée suivante de
plusieurs modes de réalisation, faite en référence aux dessins joints, donnés à titre d'exemples non limitatifs, sur lesquelsAdvantageous embodiments are described in the dependent claims. These and other features and advantages of the present invention will become more apparent in the following detailed description of several embodiments, with reference to the accompanying drawings, given by way of non-limiting examples, on which
La figure 1 est une vue en section transversale d'une partie d'une prothèse, où la surface externe de la prothèse est un élastomère silicone qui est chimiquement modifié pour le rendre hydrophile ;Fig. 1 is a cross-sectional view of a portion of a prosthesis, where the outer surface of the prosthesis is a silicone elastomer which is chemically modified to render it hydrophilic;
La figure 2 est une vue en section transversale d'une partie d'une prothèse ayant une pluralité de microparticules hydrophiles partiellement noyées dans la surface externe de la prothèse ; etFig. 2 is a cross-sectional view of a portion of a prosthesis having a plurality of hydrophilic microparticles partially embedded in the outer surface of the prosthesis; and
La figure 3 est une vue en section transversale d'une partie d'une prothèse ayant une couche hydrophile revêtue sur la surface externe de la prothèse.Figure 3 is a cross-sectional view of a portion of a prosthesis having a hydrophilic layer coated on the outer surface of the prosthesis.
La présente invention consiste à répondre au problème d'une contracture capsulaire post-implantation en attaquant l'interaction hydrophobe/hydrophobe entre la surface de la prothèse, qui dans l'art antérieur est généralement une surface hydrophobe, et des bactéries potentiellement colonisantes, également hydrophobes. Si on perturbe la capacité de la surface externe à devenir un substrat ou un support pour une croissance bactérienne, alors la bactérie ne pourra pas s'attacher à cette surface ni produire un bio film protecteur, avec les conséquences néfastes induites décrites ci-dessus. Si la bactérie reste dans un tissu hydrophile et/ou un fluide hydrophile, alors elle ne pourra pas se fixer à la surface de la prothèse, et la réponse immunitaire normale de l'hôte « nettoiera » la bactérie d'une manière connue. L'invention prévoit donc de rendre hydrophile la prothèse, réalisée en élastomère, notamment en silicone, pour empêcher toute croissance bactérienne.The present invention consists in responding to the problem of post-implantation capsular contracture by attacking the hydrophobic / hydrophobic interaction between the surface of the prosthesis, which in the prior art is generally a hydrophobic surface, and potentially colonizing bacteria, also hydrophobic. If one disrupts the ability of the outer surface to become a substrate or a support for bacterial growth, then the bacterium will not be able to attach to this surface or produce a bio-protective film, with the adverse consequences induced described above. If the bacterium remains in a hydrophilic tissue and / or a hydrophilic fluid, then it will not be able to attach to the surface of the prosthesis, and the normal immune response of the host will "clean" the bacterium in a known manner. The invention therefore provides for making the prosthesis hydrophilic, made of elastomer, in particular silicone, to prevent any bacterial growth.
Le mode de réalisation préféré de l'invention, qui prévoit de modifier chimiquement les groupes latéraux et/ou terminaux de la chaîne de silicone pour les rendre plus hydrophiles, sera décrit ci-après plus en détails. De préférence, les blocs de construction (ou chaînes) basiques de silicone, qui sont normalement hydrophobes, sont chimiquement modifiés pour rendre la molécule hydrophile. Ceci peut être réalisé en substituant les groupes méthyles le long du squelette en silicone par n'importe quel groupe
hydrophile. Des exemples de ces groupes hydrophiles pourraient être (de manière non limitative) des alcools, des groupes ioniques, des molécules organiques etc., utilisés seuls ou en combinaison les uns avec les autres. La substitution pourrait être réalisée à la fin de la molécule, sur toute la longueur de la molécule, ou une combinaison de ces deux variantes. La concentration de la substitution peut être modifiée pour altérer l'importance du caractère hydrophile. Selon le groupe qui est utilisé pour la substitution et selon la concentration, le caractère hydrophile du silicone pourrait se limiter à la surface où s'étendre à travers toute la couche de silicone. La figure 1 est une vue en section transversale d'une partie d'une prothèse 10 dans laquelle au moins la surface externe 12 de la prothèse est un élastomère de silicone qui est chimiquement modifiée 11 pour rendre la surface externe hydrophile. Dans ce mode de réalisation préféré de l'invention, le silicone est modifié dès le départ pour le rendre hydrophile. Après réticulation, on peut ainsi former un implant qui est hydrophile dès le départ. Or, modifier la surface d'un implant déjà existant qui est hydrophobe, comme décrits dans les documents EP-O 057 033 et FR-2 822 383, nécessite d'utiliser des moyens sophistiqués et coûteux. La présente invention permet d'obtenir les propriétés hydrophiles souhaitées de manière plus simple et moins coûteuse.The preferred embodiment of the invention, which provides for chemically modifying the side and / or end groups of the silicone chain to make them more hydrophilic, will be described hereinafter in more detail. Preferably, basic silicone building blocks (or chains), which are normally hydrophobic, are chemically modified to render the molecule hydrophilic. This can be achieved by substituting the methyl groups along the silicone backbone by any group hydrophilic. Examples of these hydrophilic groups could be (but not limited to) alcohols, ionic groups, organic molecules, etc., used alone or in combination with each other. The substitution could be carried out at the end of the molecule, over the entire length of the molecule, or a combination of these two variants. The concentration of the substitution can be modified to alter the importance of hydrophilicity. Depending on which group is used for the substitution and the concentration, the hydrophilicity of the silicone could be limited to the surface where it extends through the entire silicone layer. Figure 1 is a cross-sectional view of a portion of a prosthesis 10 in which at least the outer surface 12 of the prosthesis is a silicone elastomer that is chemically modified to render the external surface hydrophilic. In this preferred embodiment of the invention, the silicone is modified from the outset to make it hydrophilic. After crosslinking, it is thus possible to form an implant that is hydrophilic from the start. However, modifying the surface of an already existing implant which is hydrophobic, as described in documents EP-0 057 033 and FR-2 822 383, requires the use of sophisticated and expensive means. The present invention makes it possible to obtain the desired hydrophilic properties in a simpler and less expensive manner.
La totalité de la prothèse peut être fabriquée dès le départ à partir de silicone hydrophile (ou un autre élastomère approprié). En variante, l'invention peut aussi prévoir de réaliser une ébauche de prothèse en silicone hydrophobe, puis de plonger une ou plusieurs fois cette ébauche dans un silicone modifié hydrophile, pour former une ou plusieurs couches externes hydrophiles. Après cuisson ou réticulation, la prothèse obtenue aura une structure de support interne hydrophobe, et une surface externe hydrophile. Ici aussi, il n'y a pas de traitement de la surface externe d'un implant préalablement réalisé en silicone hydrophobe, mais au contraire, la surface externe de la prothèse est directement réalisée en matériau hydrophile pendant le procédé de fabrication de la prothèse.
Diverses variantes qui peuvent être utilisées en complément seront décrites ci-après. Ces variantes peuvent comprendre des traitements de la surface de l'implant, pour améliorer encore davantage les propriétés hydrophiles de ladite surface. Elles peuvent aussi comprendre l'utilisation d'un matériau bactéricide et/ou bactéhostatique, en particulier de l'argent, notamment sous forme ionique, qui aura un effet antimicrobien non toxique et qui pourra donc être utilisé pour tuer ou éliminer la bactérie si celle-ci devait malgré tout se développer sur la surface de la prothèse. Ce matériau anti-microbien peut être noyé ou contenu dans ou sur la surface de la prothèse et il peut bien entendu être utilisé en conjonction avec des propriétés de surface hydrophile de la prothèse comme mentionné ci-dessus.The entire prosthesis can be made from the outset from hydrophilic silicone (or other suitable elastomer). Alternatively, the invention may also provide for making a hydrophobic silicone prosthesis blank, and then dipping this blank one or more times in a hydrophilic modified silicone, to form one or more hydrophilic outer layers. After baking or crosslinking, the resulting prosthesis will have a hydrophobic internal support structure, and a hydrophilic external surface. Here too, there is no treatment of the external surface of an implant previously made of hydrophobic silicone, but on the contrary, the external surface of the prosthesis is directly made of hydrophilic material during the manufacturing process of the prosthesis. Various variants that can be used in addition will be described below. These variants may include treatments of the surface of the implant, to further improve the hydrophilic properties of said surface. They may also include the use of a bactericidal and / or bacteriostatic material, in particular silver, especially in ionic form, which will have a non-toxic antimicrobial effect and which can therefore be used to kill or eliminate the bacterium if the one It must still develop on the surface of the prosthesis. This antimicrobial material may be embedded in or on the surface of the prosthesis and may, of course, be used in conjunction with hydrophilic surface properties of the prosthesis as mentioned above.
Ci-après, diverses variantes de réalisation complémentaires vont être décrites de manière plus détaillée.Hereinafter, various alternative embodiments will be described in more detail.
1.- Modification chimique de la surface externe d'une prothèse.1.- Chemical modification of the external surface of a prosthesis.
Alors que la surface externe d'une prothèse peut comprendre une grande variété d'élastomères biocompatibles, le silicone est l'élastomère le plus largement utilisé pour des prothèses en tissu mou implantables. En conséquence, la modification de la surface externe d'une prothèse en silicone sera décrite à titre d'exemple non limitatif. La surface externe d'un implant en silicone selon l'invention peut être rendue encore plus hydrophile en lui attachant de manière covalente un groupe d'extrémité hydrophile, notamment à la fin du processus de fabrication, en mettant en contact la surface externe avec un réactif, tel que par exemple du bromure de cyanogène. Ces types d'agents activent la molécule pour la lier de manière covalente à d'autres molécules, fixant ainsi des molécules de préférence sur une zone dans laquelle elles n'étaient pas précédemment existantes. De cette manière des molécules hydrophiles peuvent être fixées de manière covalente à la surface de l'implant, le rendant encore plus hydrophile. En variante, un groupe d'extrémité hydrophobe peut être fixé de manière covalente à la surface en silicone, puis séparé ultérieurement, soit chimiquement sois biologiquement, pour rendre la surface hydrophile.
Encore un autre procédé pour rendre hydrophile la surface externe d'un implant en silicone consiste à revêtir la surface externe en silicone de l'implant avec du silicone comprenant des monomères ayant à la fois un groupe d'extrémité hydrophobe et un groupe d'extrémité hydrophile opposé, pour former la couche la plus externe. Ce silicone « bipolaire » pourrait être fixée de manière hydrophobe à la surface externe en silicone de l'implant, en laissant le groupe hydrophile opposé exposé à l'environnement. En variante, la surface de l'implant en silicone peut être revêtue avec une micelle hydrophobe-hydrophile.While the outer surface of a prosthesis may include a wide variety of biocompatible elastomers, silicone is the most widely used elastomer for implantable soft tissue prostheses. Consequently, the modification of the external surface of a silicone prosthesis will be described by way of non-limiting example. The external surface of a silicone implant according to the invention can be made even more hydrophilic by covalently attaching it to a hydrophilic end group, especially at the end of the manufacturing process, by putting the external surface in contact with a reagent, such as, for example, cyanogen bromide. These types of agents activate the molecule to covalently link it to other molecules, thus fixing molecules preferably over an area in which they were not previously existing. In this way hydrophilic molecules can be covalently attached to the surface of the implant, making it even more hydrophilic. Alternatively, a hydrophobic end group may be covalently attached to the silicone surface, and subsequently separated, either chemically biologically, to render the surface hydrophilic. Still another method for rendering the outer surface of a silicone implant hydrophilic is to coat the silicone outer surface of the implant with silicone comprising monomers having both a hydrophobic end group and an end group opposite hydrophilic, to form the outermost layer. This "bipolar" silicone could be hydrophobically bonded to the silicone outer surface of the implant, leaving the opposing hydrophilic group exposed to the environment. Alternatively, the surface of the silicone implant may be coated with a hydrophobic-hydrophilic micelle.
2.- Revêtement particulaire hydrophile2.- Hydrophilic particulate coating
La figure 2 est une vue en section transversale d'une partie d'une prothèse 20 ayant une pluralité de particules 21 hydrophiles biocompatibles partiellement noyées dans la surface externe 22. Une telle prothèse peut être réalisée par plusieurs procédés de fabrication. Un procédé préféré comprend les étapes de former une coquille en silicone en plongeant de manière répétée un mandrin en forme de prothèse dans une dispersion de silicone, le revêtement ainsi formé entre les plongées étant cuit. Après que la couche finale de l'élastomère silicone est formée sur la surface externe et que la coquille est d'épaisseur souhaitée, un revêtement de microparticules solides d'un matériau hydrophile biocompatible est appliqué sur la surface avant que la couche la plus externe soit complètement cuite. Le matériau hydrophile biocompatible peut être hydrophile à travers la totalité de la microparticule ou seulement sur la surface de ladite microparticule. Après que les microparticules ont été appliquées à la surface non cuite, le silicone est complètement cuit (par exemple par chauffage), de telle sorte qu'une partie noyée des microparticules est noyée dans la couche externe cuite de silicone et une partie exposée des microparticules s'étend à l'extérieur à partir de la surface de silicone. La prothèse ainsi formée peut être implantée dans le corps d'une personne.
3.- Revêtement d'un implant en silicone avec un matériau hydrophile biocompatibleFig. 2 is a cross-sectional view of a portion of a prosthesis 20 having a plurality of biocompatible hydrophilic particles 21 partially embedded in the outer surface 22. Such a prosthesis can be made by several manufacturing methods. A preferred method comprises the steps of forming a silicone shell by repeatedly dipping a prosthesis mandrel into a silicone dispersion, whereby the coating formed between the dives is fired. After the final layer of the silicone elastomer is formed on the outer surface and the shell is of desired thickness, a coating of solid microparticles of a biocompatible hydrophilic material is applied to the surface before the outermost layer is completely cooked. The biocompatible hydrophilic material may be hydrophilic throughout the entire microparticle or only on the surface of said microparticle. After the microparticles have been applied to the uncured surface, the silicone is completely cooked (for example by heating), so that an embedded portion of the microparticles is embedded in the fired outer layer of silicone and an exposed portion of the microparticles. extends outward from the silicone surface. The prosthesis thus formed can be implanted in the body of a person. 3.- Coating of a silicone implant with a biocompatible hydrophilic material
II est connu que certains biopolymères hydrophiles, tels que le collagène et l'acide hyaluronique, et des polymères hydrophiles synthétiques tel que la polyvinylpyirrolidone, qui ont un poids moléculaire inférieur àIt is known that certain hydrophilic biopolymers, such as collagen and hyaluronic acid, and synthetic hydrophilic polymers such as polyvinylpyrrolidone, which have a molecular weight less than
50 000 UMA (Unité de Masse Atomique), sont tolérés par le corps, métabolisés et/ou excrétés. En conséquence, un implant en silicone enveloppé par un film comprenant de tels polymères présentera une surface externe hydrophile. La figure 3 est une vue en section transversale d'une partie d'une prothèse 30 ayant une couche ou un film hydrophile 31 revêtu(e) sur la surface externe 32 de l'implant. Un tel film hydrophile biocompatible 31 peut être fixé soit à une surface lisse, soit à une surface texturée d'un implant en silicone.50,000 AMU (Atomic Mass Unit), are tolerated by the body, metabolized and / or excreted. Accordingly, a silicone film-wrapped implant comprising such polymers will have a hydrophilic outer surface. Figure 3 is a cross-sectional view of a portion of a prosthesis 30 having a hydrophilic layer or film 31 coated on the outer surface 32 of the implant. Such biocompatible hydrophilic film 31 may be attached to either a smooth surface or a textured surface of a silicone implant.
4.- Utilisation de composés hydrophiles liés de manière non covalente autour de l'implant4.- Use of hydrophilic compounds non-covalently bound around the implant
Toute solution, crème, composé, matériau, gel, qui est réabsorbable dans le corps et qui peut interférer avec la capacité d'une interaction hydrophobe-hydrophobe, peut être utilisé au moment de la chirurgie pour modifier, casser ou interrompre l'interaction hydrophobe-hydrophobe. Ceci peut par exemple comprendre (de manière non limitative) des matériaux de lubrification pour l'insertion de l'implant, des matériaux anti-adhésion, de la bétadine, etc. Ces matériaux peuvent être rajoutés directement à la poche pour l'implant, à la surface de l'implant lui-même, ou une combinaison des deux.Any solution, cream, compound, material, gel, that is reabsorbable in the body and that can interfere with the ability of a hydrophobic-hydrophobic interaction, can be used at the time of surgery to modify, break or interrupt the hydrophobic interaction -hydrophobe. This may for example include (but not limited to) lubricating materials for implant insertion, anti-adhesion materials, betadine, etc. These materials can be added directly to the implant pocket, on the surface of the implant itself, or a combination of both.
5.- Utilisation d'argent ou de composés ou nanoparticules contenant de l'argent pour interférer avec la croissance de bactéries dans ou sur un implant L'argent est bien connu pour être un métal avec des capacités thérapeutiques et en faible toxicité pour l'homme. Il peut être bactéricide et/ou bactéhostatique. De l'argent ou des composés contenant de l'argent ou
des nanoparticules d'argent, notamment sous forme ionique, pourrait être incorporé dans le silicone ou noyé dans la surface de la prothèse. L'argent, sous quelque forme que ce soit peut être utilisé en conjonction avec une surface externe hydrophile mentionnée précédemment, ou seul.5.- Use of silver or silver-containing compounds or nanoparticles to interfere with the growth of bacteria in or on an implant Silver is well known to be a metal with therapeutic and low-toxicity capabilities. man. It can be bactericidal and / or bacteriostatic. Money or compounds containing money or silver nanoparticles, especially in ionic form, could be incorporated in the silicone or embedded in the surface of the prosthesis. Silver in any form can be used in conjunction with a previously mentioned hydrophilic external surface, or alone.
Bien que la présente invention ait été décrite en référence à plusieurs variantes, il est entendu qu'un homme du métier peut y apporter toute modification utile sans sortir du cadre de la présente invention tel que défini par les revendications annexées.
Although the present invention has been described with reference to several variants, it is understood that a person skilled in the art can make any useful modification without departing from the scope of the present invention as defined by the appended claims.
Claims
1.- Prothèse chirurgicale (10 ; 20 ; 30) destinée à être implantée dans un corps pour la reconstitution plastique, ladite prothèse (10 ; 20 ; 30) étant en contact avec des tissus du corps, caractérisée en ce que ladite prothèse (10 ; 20 ; 30) comporte une surface externe (12 ; 22 ; 32) qui est hydrophile pour au moins partiellement empêcher la fixation et/ou le développement de bactéries, notamment du type hydrophobe, sur ladite surface externe (12 ; 22 ; 32).1.- Surgical prosthesis (10; 20; 30) intended to be implanted in a body for plastic reconstitution, said prosthesis (10; 20; 30) being in contact with tissues of the body, characterized in that said prosthesis (10; 20; 30) has an outer surface (12; 22; 32) which is hydrophilic to at least partially prevent the attachment and / or development of bacteria, especially hydrophobic type, on said outer surface (12; 22; 32) .
2.- Prothèse selon la revendication 1 , dans laquelle ladite prothèse (10 ; 20 ; 30) est réalisée en élastomère, notamment en silicone, ledit élastomère étant modifié et rendu hydrophile avant fabrication de ladite prothèse.2. The prosthesis according to claim 1, wherein said prosthesis (10; 20; 30) is made of elastomer, in particular silicone, said elastomer being modified and rendered hydrophilic before manufacture of said prosthesis.
3.- Prothèse selon la revendication 2, dans laquelle ladite surface externe (22) comprend en outre une pluralité de microparticules hydrophiles biocompatibles (21 ) partiellement noyées dans l'élastomère hydrophile.The prosthesis of claim 2, wherein said outer surface (22) further comprises a plurality of biocompatible hydrophilic microparticles (21) partially embedded in the hydrophilic elastomer.
4.- Prothèse selon la revendication 2 ou 3, dans laquelle ladite surface externe (12) est rendue encore plus hydrophile par une modification de silice contenue dans ladite surface externe.4. The prosthesis according to claim 2 or 3, wherein said outer surface (12) is made even more hydrophilic by a modification of silica contained in said outer surface.
5.- Prothèse selon l'une quelconque des revendications 2 à 4, dans laquelle des groupes d'extrémités hydrophiles sont attachés au silicone par une liaison covalente.5. The prosthesis according to any one of claims 2 to 4, wherein hydrophilic end groups are attached to the silicone by a covalent bond.
6.- Prothèse selon l'une quelconque des revendications 2 à 5, dans laquelle ladite surface externe (32) comprend un revêtement (31 ) d'un film hydrophile biocompatible. The prosthesis of any one of claims 2 to 5, wherein said outer surface (32) comprises a coating (31) of a biocompatible hydrophilic film.
7.- Prothèse selon l'une quelconque des revendications 2 à 6, dans laquelle ladite surface externe (32) est revêtue d'une substance organique hydrophile (31 ) de manière covalente ou ionique.The prosthesis of any one of claims 2 to 6, wherein said outer surface (32) is coated with a hydrophilic organic substance (31) in a covalent or ionic manner.
8.- Prothèse selon l'une quelconque des revendications précédentes, dans laquelle la surface externe de la prothèse est revêtue par et/ou contient un matériau bactéricide et/ou bactériostatique pour éliminer et/ou empêcher la croissance et/ou la métabolisation d'une contamination bactérienne autour, sur et/ou dans ladite prothèse.8. Prosthesis according to any one of the preceding claims, wherein the outer surface of the prosthesis is coated with and / or contains a bactericidal material and / or bacteriostatic to eliminate and / or prevent the growth and / or metabolism of bacterial contamination around, on and / or in said prosthesis.
9.- Prothèse selon la revendication 8, dans laquelle ledit matériau bactéricide et/ou bactériostatique comprend de l'argent, des composés d'argent ou des nano-particules d'argent, ou des alliages comportant un tel matériau.The prosthesis of claim 8, wherein said bactericidal and / or bacteriostatic material comprises silver, silver compounds or silver nano-particles, or alloys comprising such material.
10.- Procédé de fabrication d'une prothèse selon l'une quelconque des revendications précédentes, comprenant les étapes de fournir un élastomère, tel que du silicone, de modifier ledit élastomère pour le rendre hydrophile, et d'utiliser ledit élastomère modifié pour fabriquer une prothèse au moins partiellement hydrophile.The method of manufacturing a prosthesis according to any one of the preceding claims, comprising the steps of providing an elastomer, such as silicone, modifying said elastomer to render it hydrophilic, and using said modified elastomer to manufacture an at least partially hydrophilic prosthesis.
11.- Procédé selon la revendication 10, dans lequel une ébauche de prothèse en élastomère hydrophobe est plongé, de préférence plusieurs fois, dans un élastomère modifié hydrophile, puis réticulé, afin de fabriquer une prothèse ayant un support interne hydrophobe et une surface externe hydrophile.11. The method of claim 10, wherein a hydrophobic elastomer prosthesis blank is dipped, preferably several times, in a hydrophilic modified elastomer, and then crosslinked, to produce a prosthesis having a hydrophobic internal support and a hydrophilic outer surface. .
12.- Procédé selon la revendication 10 ou 11 , dans lequel l'étape de modifier l'élastomère est réalisée chimiquement en substituant les groupes méthyles des molécules d'élastomère par des groupes hydrophiles. The method of claim 10 or 11, wherein the step of modifying the elastomer is performed chemically by substituting the methyl groups of the elastomer molecules with hydrophilic groups.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0758663A FR2922773A1 (en) | 2007-10-29 | 2007-10-29 | SURGICAL PROSTHESIS |
PCT/EP2008/064604 WO2009056542A1 (en) | 2007-10-29 | 2008-10-28 | Surgical prosthesis for plastic reconstruction |
Publications (1)
Publication Number | Publication Date |
---|---|
EP2217292A1 true EP2217292A1 (en) | 2010-08-18 |
Family
ID=39402645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP08845613A Withdrawn EP2217292A1 (en) | 2007-10-29 | 2008-10-28 | Surgical prosthesis for plastic reconstruction |
Country Status (4)
Country | Link |
---|---|
US (1) | US20100234945A1 (en) |
EP (1) | EP2217292A1 (en) |
FR (1) | FR2922773A1 (en) |
WO (1) | WO2009056542A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE202009007115U1 (en) * | 2009-05-18 | 2010-06-02 | Amoena Medizin-Orthopädie-Technik GmbH | breast prosthesis |
WO2013112378A2 (en) * | 2012-01-24 | 2013-08-01 | Bvw Holding Ag | Implantable superhydrophobic surfaces |
US10292806B2 (en) | 2013-01-11 | 2019-05-21 | Bvw Holding Ag | Implantable superhydrophobic surfaces |
LT3484535T (en) | 2016-07-14 | 2022-02-10 | Hollister Incorporated | Hygienic medical devices having hydrophilic coating and methods of forming the same |
EP3391914B1 (en) * | 2017-04-21 | 2021-07-14 | Safe Implant Technology ApS | Gold particles for use in therapy to prevent or reduce capsular contracture |
ES2923280B2 (en) * | 2022-03-15 | 2023-10-26 | American Erectil Device Srl | PENIS IMPLANT WITH SYNTHETIC CAVERNOUS BODIES AND BACTERICIDAL BARRIER |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2498446B1 (en) * | 1981-01-26 | 1985-05-24 | Inst Nat Sante Rech Med | METHOD FOR TREATING A BREAST-PROSTHESIS AND PROSTHESIS OBTAINED |
WO2000064506A1 (en) * | 1999-04-23 | 2000-11-02 | Agion Technologies, L.L.C. | Stent having antimicrobial agent |
FR2822383B1 (en) * | 2001-03-23 | 2004-12-17 | Perouse Lab | PROSTHESIS FOR PLASTIC RECONSTRUCTION WITH IMPROVED HYDROPHILICITY PROPERTIES, AND METHOD FOR OBTAINING SAME |
US6913626B2 (en) * | 2001-08-14 | 2005-07-05 | Mcghan Jim J. | Medical implant having bioabsorbable textured surface |
-
2007
- 2007-10-29 FR FR0758663A patent/FR2922773A1/en not_active Withdrawn
-
2008
- 2008-10-28 EP EP08845613A patent/EP2217292A1/en not_active Withdrawn
- 2008-10-28 US US12/740,076 patent/US20100234945A1/en not_active Abandoned
- 2008-10-28 WO PCT/EP2008/064604 patent/WO2009056542A1/en active Application Filing
Non-Patent Citations (1)
Title |
---|
See references of WO2009056542A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO2009056542A1 (en) | 2009-05-07 |
US20100234945A1 (en) | 2010-09-16 |
FR2922773A1 (en) | 2009-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5064350B2 (en) | Method for producing antibacterial polymer surface | |
Romanò et al. | Hyaluronic acid and its composites as a local antimicrobial/antiadhesive barrier | |
EP2217292A1 (en) | Surgical prosthesis for plastic reconstruction | |
JP2665399B2 (en) | Antimicrobial-coated medical implants | |
Shahid et al. | The prospects of antimicrobial coated medical implants | |
Neethirajan et al. | Medical biofilms—nanotechnology approaches | |
EP0641225B1 (en) | Utilisation of cross-linked collagen for the fabrication of a stitchable, biocompatible, slow resorption membrane | |
US8945217B2 (en) | Medical devices incorporating ceragenin-containing composites | |
Roosjen et al. | The use of positively charged or low surface free energy coatings versus polymer brushes in controlling biofilm formation | |
US11052177B2 (en) | Antimicrobial polymer layers | |
CA2704962A1 (en) | Antimicrobial coatings for medical devices containing a polypeptide that generates hydrogen peroxide upon exposure to a ligand and methods for making and using them | |
LU82102A1 (en) | BIOCOMPATIBLE AND BLOOD COMPATIBLE MATERIALS AND METHODS OF MAKING SAME | |
MXPA05006631A (en) | Method for making medical devices having antimicrobial coatings thereon. | |
JP2005523116A (en) | Implantable medical device having a biologically active polymer casing | |
JP2000507842A (en) | Triclosan-containing drug device | |
AU2017376835A1 (en) | A medical implant and a method of coating a medical implant | |
KR20130045836A (en) | Biofilm resistant materials | |
Delaviz et al. | Infection resistant biomaterials | |
Dhiman et al. | Silver-based polymeric nanocomposites as antimicrobial coatings for biomedical applications | |
Sun et al. | Inspired by the periodontium: a universal bacteria-defensive hydrogel for preventing percutaneous device-related infection | |
EP0954341B1 (en) | Intraocular lens containing releasable medication | |
EP3010942B1 (en) | Surface modification of medical or veterinary devices | |
RU2462273C1 (en) | Method for processing synthetic textile implanted blood contact medical devices | |
FR2959938A1 (en) | Urinary probe for use by patient to reduce and/or eliminate e.g. urinary infections, has vaccinium macrocarpon extract containing anthocyanin precursors applied by adsorption, absorption, coating or physicochemical application process | |
Zhu et al. | Anti-biofouling and antimicrobial biomaterials for tissue engineering |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20100528 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA MK RS |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20110411 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20110503 |